Related Experiment Videos

Application of a membrane fusion assay for rapid drug screening

S S Vogel1, S Beushausen, D S Lester

  • 1Laboratory of Theoretical and Physical Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

Pharmaceutical Research
|October 1, 1995
PubMed
Abstract

Insights

A new assay screens drugs for effects on cell membranes using sea urchin eggs. Tamoxifen disrupted membranes, while Taxol inhibited secretion, demonstrating the assay's potential for identifying membrane-active drugs.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Membrane fusion and organelle lysis are critical cellular processes.
  • Identifying drugs that modulate these processes is essential for therapeutic development.

Purpose of the Study:

  • To develop a novel in vitro assay for screening drug effects on membrane fusion and organelle lysis.
  • To assess the assay's utility in identifying membrane-active compounds.

Main Methods:

  • A 96-well microtiter-dish turbidimetric assay was employed.
  • Membrane components from sea urchin eggs were utilized as the biological system.
  • The assay monitored granule fusion and/or lysis.

Main Results:

  • 16 out of 18 screened drugs showed no effect on membrane integrity or fusion.
  • Tamoxifen, an antineoplastic drug, disrupted intracellular membranes independently of calcium.
  • Taxol, another antineoplastic drug, specifically inhibited calcium-triggered exocytosis.

Conclusions:

  • The developed assay is cost-effective, simple, rapid, and ethically sound, avoiding animal sacrifice.
  • This assay can effectively identify drugs that are membrane-active.
  • The assay has the potential to identify drugs that specifically interfere with secretion processes.

Related Concept Videos